Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Ivermectin  COVID-19 treatment studies for Ivermectin  C19 studies: Ivermectin  Ivermectin   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation
Hirsch et al., Microbiology & Infectious Diseases
Hirsch et al., Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation, Microbiology & Infectious Diseases
Jan 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Report on ivermectin prophylaxis for healthcare workers in a hospital in Argentina, showing 0 cases in the 162 participants. Dosage was 0.2mg/kg weekly for eight weeks, followed by 4 months rest.
Hirsch et al., 6 Jan 2021, peer-reviewed, 2 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperIvermectinAll
Abstract: Review Article ISSN 2639-9458 Microbiology & Infectious Diseases Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation Hirsch, Roberto R1* and Carvallo, Hector E2 Former Professor of Infectology, University of Buenos Aires, Argentina. Director Career for Infectology Specialist, Hospital F. J. Muñíz, Argentina. Director Department of Infectious Diseases, Hospital F. J. Muñíz, Argentina. 1 Former Professor of Internal Medicine, University of Buenos Aires, Argentina. Former Director of Ezeiza´s Public Hospital, Argentina. Professor of Internal Medicine, Universidad Abierta Interamericana, Argentina. 2 * Correspondence: Roberto R Hirsch, Former Professor of Infectology, University of Buenos Aires, Argentina, E-mail: rrhirsch@intramed.net. Received: 29 November 2020; Accepted: 22 December 2020 Citation: Hirsch RR, Carvallo, Héctor E. Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation. Microbiol Infect Dis. 2020; 4(4): 1-8. ABSTRACT The current SARS COV2 (COVID 19) pandemic has generated a high number of infections among Health Agents. Around 25% of them have had to leave - temporarily or permanently - their jobs, due to having contracted the disease. Likewise, numerous deaths have been lamented within this group, which acts as the first defense against this and other pathologies that threaten the individual. All this has happened despite Personal Protective Equipments (PPEs), which makes it essential to optimize -from the pharmacological point of view- these elements, in order to reduce the risk of contagion as much as possible. In this sense, Ivermectin has shown its usefulness against SARS COV2, both in treatment and in prophylaxis. Therefore, this work compiles the characteristics of the group of Health Agents (and their close contacts) from a Buenos Aires Hospital specialized in Infectious Diseases, who resorted to it, as well as the results that were obtained. Keywords protein S (spike) [1].
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit